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Abstract
Background: Deep venous thrombosis (DVT) and pulmonary embolism (PE) are recognized as major causes of morbidity and mortality in orthopaedic trauma patients. Despite the high incidence of these complications following orthopaedic trauma, there is a paucity of literature investigating the clinical risk factors for DVT in this specific population. As our healthcare system increasingly emphasizes quality measures, it is critical for orthopaedic surgeons to understand the clinical factors that increase the risk of DVT following orthopaedic trauma.
Objectives: Utilizing the ACS-NSQIP database, we sought to determine the incidence and identify independent risk factors for DVT following orthopaedic trauma.
Patients and Methods: Using current procedural terminology (CPT) codes for orthopaedic trauma procedures, we identified a prospective cohort of patients from the 2006 to 2013 ACS-NSQIP database. Using Wilcoxon-Mann-Whitney and chi-square tests where appropriate, patient demographics, comorbidities, and operative factors were compared between patients who developed a DVT within 30 days of surgery and those who did not. A multivariate logistic regression analysis was conducted to calculate odds ratios (ORs) and identify independent risk factors for DVT. Significance was set at P < 0.05.
Results: 56,299 orthopaedic trauma patients were included in the analysis, of which 473 (0.84%) developed a DVT within 30 days. In univariate analysis, twenty-five variables were significantly associated with the development of a DVT, including age (P < 0.0001), BMI (P = 0.037), diabetes (P = 0.01), ASA score (P < 0.0001) and anatomic region injured (P < 0.0001). Multivariate analysis identified several independent risk factors for development of a DVT including use of a ventilator (OR = 43.67, P = 0.039), ascites (OR = 41.61, P = 0.0038), steroid use (OR = 4.00, P < 0.001), and alcohol use (OR = 2.98, P = 0.0370). Compared to patients with upper extremity trauma, those with lower extremity injuries had significantly increased odds of developing a DVT (OR = 7.55, P = 0.006). The trend toward increased odds of DVT among patients with injuries to the hip/pelvis did not reach statistical significance (OR = 4.51, P = 0.22). Smoking was not found to be an independent risk factor for developing a DVT (P = 0.1217).
Conclusions: This is the largest study to date using the NSQIP database to identify risk factors for DVT in orthopaedic trauma patients. Although the incidence of DVT was low in our cohort, the presence of certain risk factors significantly increased the odds of developing a DVT following orthopaedic trauma. These findings will enable orthopaedic surgeons to target at-risk patients and implement post-operative care protocols aimed at reducing the morbidity and mortality associated with DVT in orthopaedic trauma patients.
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1. BackgroundTraumatic injury results in significant physiologic changes that place trauma patients at elevated risk for venous thromboembolism (VTE), a term that encompass-es both deep venous thrombosis (DVT) and pulmonary embolism (PE). Serum levels of inflammatory cytokines (including interleukin-6 (IL-6), IL-8, and tumor necrosis factor-alpha), procoagulant microparticles, and throm-bin are increased following trauma. This systemic inflam-matory response results in a hypercoagulable state that increases the likelihood of developing VTE (1). Hyperco-
agulability, along with endothelial injury and venous sta-sis, comprise Virchow’s Triad, the set of conditions that contributes to venous thrombosis. Due to the frequent requirement for post-operative immobilization and pro-tected weight bearing following orthopaedic trauma surgery, all three conditions of Virchow’s Triad are often present in these patients (2).Prior to the implementation of routine thrombopro-phylaxis, reported rates of VTE following major trauma were extremely high. Geerts et al. reported a 58% inci-
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dence of lower extremity DVT and a 0.9% incidence of fatal PE in 349 patients admitted for major traumatic injuries who did not receive thromboprophylaxis (3). De-spite its relatively low incidence compared to DVT, PE is still the third most common cause of in-hospital death among trauma patients (4). DVT rates also vary by ana-tomic region injured, ranging from 50% in patients with abdominal, thoracic, or facial injuries to 80% in patients with femur fractures (3). Numerous risk factors for DVT have been reported in the trauma literature, including age, injury severity, polytrauma, fracture of the pelvis, femur, or tibia, spinal cord injury, central vein cannula-tion, number of procedures, and medical comorbidities including diabetes and obesity (3, 5-8).Both chemical and mechanical thromboprophylaxis have been shown to decrease rates of VTE in the setting of trauma (9, 10). Pharmacologic prophylaxis with low-molecular weight heparin (LMWH) was shown to sig-nificantly decrease the incidence of both DVT and PE in a large cohort of more than 2200 trauma patients (11). And mechanical prophylaxis with pneumatic sequen-tial compression devices (SCDs) significantly decreased VTE incidence from 4% to 11% (P = 0.02) in a prospective randomized controlled trial of 300 orthopaedic trauma patients compared with no VTE prophylaxis (12). A grow-ing understanding of the importance of thrombopro-phylaxis in trauma patients has led to the development of institutional protocols for VTE prophylaxis at trauma centers around the world. Additionally, several profes-sional organizations have published clinical guidelines for thromboprophylaxis in trauma patients (9, 13, 14).However, protocols differ widely, and even with appro-priate prophylaxis, DVT and PE still occur following ortho-paedic trauma. A prospective cohort study of more than 300 orthopaedic trauma patients reported a VTE rate of 11.5% despite thromboprophylaxis (10). In a study of 200,000 orthopaedic trauma patients receiving throm-boprophylaxis, the overall incidence of PE was still 0.46%, and the in-hospital mortality rate among patients who developed a PE was 12% (5). Identifying those patients who are at greatest risk for the development of VTE following orthopaedic trauma may enable surgeons to implement targeted protocols to decrease rates of VTE among these high-risk patients, thereby decreasing the morbidity and mortality associated with DVT and PE.Large-scale databases such as the national trauma data bank (NTDB) are useful resources for conducting large-scale analyses of outcomes. However Kardooni et al. re-cently reported on the potential hazards of utilizing the NTDB for this purpose (15). The national surgical quality improvement program (NSQIP) database is a high-quali-ty, multicenter dataset that has been utilized extensively to study outcomes in surgical patients (16-21).
2. ObjectivesUtilizing the NSQIP database, the purpose of our study 
was to determine the incidence of DVT following ortho-paedic trauma surgery and to identify independent risk factors for the development of DVT in orthopaedic trau-ma patients.
3. Patients and Methods
3.1. Data ExtractionInstitutional Review Board approval was obtained, and our study complies with the ethical guidelines of the 1975 Declaration of Helsinki. Access to the NSQIP data-set collected between 2005 and 2013 was granted by the American College of Surgeons. The 135 patient variables reported within this multi-center database include pre-operative risk factors, intraoperative variables, and 30-day postoperative mortality and morbidity outcomes for patients undergoing major surgical procedures in both inpatient and outpatient settings. At each participating institution, two risk-assessment nurses trained as Sur-gical Clinical Reviewers (SCR) were appointed to collect data directly from patients’ medical records. Inter-rater reliability disagreement of < 5% per site was considered acceptable. Audit reports of NSQIP data collection have identified disagreement rates of < 1.8% (22).
3.2. Patient SelectionFrom the entire 2005-2013 NSQIP database, we included only patients who underwent an orthopaedic trauma procedure as defined by current procedural terminol-ogy (CPT) codes for orthopaedic trauma (n = 89). Patient demographics including age, gender, and race were re-corded, along with preoperative comorbidities including body mass index (BMI), recent weight loss (greater than 10% in the last 6 months), insulin dependent diabetes mellitus, smoking status, alcohol use, functional status, dyspnea, history of chronic obstructive pulmonary dis-ease (COPD), congestive heart failure (CHF), hypertension requiring medication, history of esophageal varices, dis-seminated cancer, steroid use, bleeding disorders, hemo-dialysis, chemotherapy within 30 days of surgery, and radiotherapy within 90 days of surgery. Operative factors including systemic inflammatory response syndrome (SIRS), sepsis, or septic shock at time of surgery, operative time, wound class, and American society of anesthesiolo-gists (ASA) score were also recorded. Institutional throm-boprophylaxis protocols were followed at each site.
3.3. Data AnalysisUsing Wilcoxon-Mann-Whitney and chi-square tests where appropriate, patient demographics, comorbidi-ties, and operative factors were compared between pa-tients who developed a DVT within 30 days and those who did not. Using a multivariate logistic regression analysis, odds ratios (ORs) for DVT were calculated to determine independent risk factors for DVT.
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Statistical analysis was performed using Stata 12 (Stata-Corp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP) and SSPS Statistics (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). Significance was set at P < 0.05.
4. ResultsApplication of our inclusion criteria to the NSQIP da-tabase yielded 56,299 orthopaedic trauma patients who were included in the analysis. Patient demographics are shown in Table 1. 473 patients developed a DVT within 30 days of surgery, representing an overall DVT incidence of 0.84%.Unadjusted univariate analysis using Wilcoxon-Mann-Whitney and chi square tests where appropriate identi-fied twenty-five patient variables that were significantly associated with the development of a DVT, including age (P < 0.0001), BMI (P = 0.0377), diabetes (P = 0.01), ASA score (P < 0.0001) and anatomic region injured (P < 0.0001). The complete univariate analysis is included in Table A1.Multivariate analysis identified seven independent risk factors for development of a DVT. As shown in Figure 1, the use of a ventilator increased the odds of DVT by 43.67 times (P = 0.039) while ascites increased the odds of DVT 41.61 times (P = 0.0038). Alcohol use (OR = 2.98, P = 0.037) and steroid use (OR = 4.00, P < 0.001) were also indepen-dent risk factors for DVT following orthopaedic trauma, as was the presence of sepsis (OR = 5.43, P = 0.001) and gangrene (OR = 5.14, P = 0.0175). Compared to patients with upper extremity trauma, those with lower extremity injuries had 7.55 times (CI: 1.78 - 32.04, P = 0.006) greater odds of developing a DVT within 30 days. As shown in Figure 2, the trend toward greater odds of DVT among patients with injuries to the hip/pelvis did not reach sta-tistical significance (OR = 4.51, CI: 0.39 - 52.50, P = 0.229).
Table 1. Patient Demographics
DVT No DVT P Value
Age (mean) 79 72 < 0.0001
BMI (mean) 25.4 25.0 0.037
Frequency a 473 (0.08) 55826 (99.2) NA
Location a < 0.0001Upper extremity 30 (6.34) 11373 (20.4)Lower extremity 433 (91.54) 42819 (76.7)Hip/pelvis 6 (1.3) 762 (1.4)
ASA Status a < 0.00011 15 (3.17) 5423 (9.7)2 101 (21.4) 17631 (31.6)3 253 (53.5) 26070 (46.7)4 104 (22.0) 6577 (11.8)Abbreviation: NA, not available.aValues are presented as No (%).
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Figure 1. Multivariate Analysis Showing Odds Ratio DVT
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Figure 2. Multivariate Analysis of Odds Ratio DVT by Region Injured
Smoking was not found to be an independent risk fac-tor for developing a DVT (P = 0.122), nor was ASA score (P = 0.403), BMI (P = 0.163), or diabetes (P = 0.418). The com-plete multivariate analysis is included in Table A2
5. DiscussionDespite the abundance of literature relevant to VTE in the general trauma population, high-quality evidence specific to VTE prophylaxis and treatment in the ortho-paedic trauma population is relatively limited. Stannard et al. reported a DVT rate of 11.5% in a prospective cohort of 312 patients who sustained high-energy skeletal trau-ma despite pharmacologic prophylaxis (23). Using the national trauma data bank (NTDB), Godzik et al. investi-gated the incidence of PE in 200,000 patients with pelvic and lower-extremity fractures who received thrombopro-phylaxis according to the protocols of each institution (5). The overall incidence of PE was 0.46%, and the in-hos-pital mortality rate among patients who developed a PE was 12%. These authors also identified independent risk factors for PE in this patient population including multi-ple fractures, history of warfarin use, morbid obesity, and emergency department disposition to an intensive care unit or to the operating room. These studies underscore the fact that both DVT and PE still occur despite routine VTE prophylaxis.
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Table 2. Literature Review of Incidence and Risk Factors for Venous Thromboembolism in Orthopaedic Trauma
Study Study Design, Patient Popula-
tion
N Prophylaxis 
used?
Incidence of 
VTE
Risk factors for VTE identified
Geerts et al. (3) Single center prospective cohort, major trauma patients 349 No 58% (1% fatal PE) Age, blood transfusion, surgery, fracture of the femur or tibia, and spinal cord injury.
O'Malley et al. (6) Single center retrospective cohort, major trauma patients 1,316 Yes 2.3% (PE) Age > 55 years, multi-system injury, cannulation of central veins, and pelvic fractures (but not long-bone fractures) 
Paffrath et al. (7) Multicenter retrospective cohort, major trauma patients 7,937 Yes 1.8% (PE) ISS score, Pelvic AIS score 2 or higher, # of operations, medical comorbidities (diabetes, renal failure, malignancy, coagulation disorders)
Tuttle-Newhall et 
al. (8)
State-wide trauma registry, major trauma patients 318,554 Yes 0.3% (PE) Age > 55 years, increasing ISS and AIS (extremity, soft tissue, chest regions), 
Godzik et al. (5) Retrospective Database Review, Ortho Trauma Patients 199,952 Yes 0.46% (PE) Multiple fractures, history of warfarin use, morbid obesity, ED disposition to ICU or OR
Fisher et al. (12) Prospective RCT (SCDs vs. None), Ortho Trauma Patients 304 Yes/No 11% vs. 4% 11% incidence for control group, 4% incidence in experimental group
Stannard et al. 
(10)
Prospective Cohort Study, Ortho Trauma Patients 312 Yes 11.5% 11.5% incidence of VTE despite prophylaxis
 Table 2 summarizes the existing literature document-ing VTE incidence and risk factors following orthopae-dic trauma. Only three of the seven referenced studies are specific to an orthopaedic trauma population. The other four studies include major trauma patients, and al-though many of these patients also have orthopaedic in-juries, the conclusions of these studies are not necessar-ily generalizable to an orthopaedic trauma population.Large-scale databases offer significant advantages for determining population-based epidemiologic data. Uti-lizing such databases avoids the significant costs and inconvenience of conducting large multi-center studies. Although the NTDB has been used to investigate VTE in-cidence and risk factors in orthopaedic trauma, a recent article reported on the potential hazards of utilizing this particular database for this purpose due to the signifi-cant variability in practices for reporting complications among the participating institutions (15). Therefore, we decided to utilize the ACS-NSQIP database for our study, which has a standardized protocol for reporting com-plications. Inter-rater disagreement rates of < 1.8% have been reported among the surgical clinical reviewers who record outcomes data directly from patients’ charts.Ours is the largest study to date utilizing the NSQIP da-tabase to identify risk factors for DVT in orthopaedic trau-ma patients. Although the incidence of DVT (0.84%) was low in our cohort, the presence of certain risk factors sig-nificantly increased the odds of developing a DVT follow-ing orthopaedic trauma. A ventilator requirement and the presence of sepsis, both markers of severity of illness, were identified as risk factors in our study. These findings 
are consistent with those of Paffrath and Tuttle-Newhall, who reported increased rates of DVT with increasing in-jury severity (7, 8). The presence of ascites, a marker of end-organ dysfunction, is also consistent with previous reports of renal failure as an independent risk factor for DVT (7). Our study is the first to identify steroid use and alcohol use as DVT risk factors. Furthermore, compared with upper extremity fractures, our study demonstrated significantly increased odds of DVT with lower extrem-ity fractures as well as a nonsignificant trend toward increased odds with pelvic fractures. These findings sub-stantiate previous reports of higher DVT rates in femur, tibia, and pelvic fractures (3, 6).Our study does have some limitations. Although insti-tutional protocols for DVT prophylaxis were followed for this cohort, the NSQIP database does not permit an assessment of the thromboprophylaxis status of each pa-tient. Certain associated injuries or other medical condi-tions may represent a contra-indication to pharmacolog-ic anticoagulation, and the impact of this variable on our results could not be assessed. In addition, smoking was not found to be an independent risk factor for DVT in our study even though tobacco use has been associated with increased DVT risk (24). This is likely due to the fact that our cohort had an extremely low overall incidence of DVT (0.84%) combined with a relatively low rate of smoking (less than 20% of the cohort). Finally, the NSQIP database does not permit an assessment of the specific thrombo-prophylactic agent(s) administered and the timing or du-ration of their administration, variables that have been shown to impact DVT rates in other studies (25-28).
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These limitations notwithstanding, our study used a reli-able large-scale database to identify several independent risk factors for DVT following orthopaedic trauma surgery, many of which had not previously been reported in the lit-erature. In so doing, our study contributes meaningfully to the growing body of literature aimed at identifying fac-tors that place orthopaedic trauma patients at increased risk for VTE. Such knowledge will enable surgeons to de-velop and implement effective post-operative VTE prophy-laxis protocols aimed at reducing the morbidity and mor-tality associated with DVT following orthopaedic trauma.
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